close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar26Point61
Implied share price

Buy Undervalued by 86.9%

5% margin of safety What's this?

EV / EBITDA
Use Average
KG
King Pharmaceuticals, Inc.
SNY
Sanofi SA (ADR)
Change
DNA
Genentech, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
AMGN
Amgen, Inc.
Change
12.67 6.65 6.52 17.08 21.38 9.0
All amounts in millions
from last financial year
         
Implied Share Price $26.61 $112.81 $71.28 $31.45 $148.48
Market Cap 3,559 145,886 100,042 85,313 78,395
Net Debt -148 8,094 -3,369 6,361 2,468
Enterprise Value (EV) 3,411 80,938 96,673 91,674 80,863
Revenue 1,776 35,957 13,418 9,702 17,265
EBITDA 513 12,422 5,661 4,288 8,985
Percent 28.9 % 34.5 % 42.2 % 44.2 % 52.0 %
EBIT 298 7,825 5,069 4,010 7,500
Percent 16.8 % 21.8 % 37.8 % 41.3 % 43.4 %
Balance Sheet          
Total Assets 3,328 100,407 21,787 21,239 54,298
Total Liabilities 959 43,069 6,116 11,930 35,238
Shareholders Equity 2,369 57,338 15,671 9,309 19,060.0

Price history

Comments

No comments yet. Login to comment.